Clinical Trials Browser

Phase 2 × Frailty × Dasatinib × Clear all

NCT04733534 2026-04-24

An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer

Phase 2 Active not recruiting

Frailty, Neoplasms